For the past two decades, Collegium Pharmaceutical has been focused on developing and commercializing new medicines for pain management. Today, our mission is to build a leading, diversified specialty pharmaceutical company that reflects our Core Values and our commitment to improving the lives of people living with serious medical conditions. The result of those efforts is a portfolio of meaningfully differentiate medications to treat serious medical conditions, including moderate-to-severe pain and acute migraine.
Data Provided by Refinitiv. Minimum 15 minutes delayed.